These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15184302)

  • 1. Lepirudin anaphylaxis and Kounis syndrome.
    Koutsojannis CM; Kounis NG
    Circulation; 2004 Jun; 109(22):e315; author reply e315. PubMed ID: 15184302
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
    Greinacher A; Lubenow N; Eichler P
    Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of anaphylaxis after reexposure to intravenous lepirudin in patients with current or past heparin-induced thrombocytopenia.
    Cardenas GA; Deitcher SR
    Mayo Clin Proc; 2005 Apr; 80(4):491-3. PubMed ID: 15819285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia.
    Badger NO; Butler K; Hallman LC
    Pharmacotherapy; 2004 Dec; 24(12):1800-3. PubMed ID: 15585446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal anaphylactic shock caused by lepirudin.
    Prescrire Int; 2003 Apr; 12(64):64. PubMed ID: 12674127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug safety. Notes about surveillance].
    Moreno Alvarez PJ; Madurga Sanz M
    Farm Hosp; 2003; 27(1):60-3. PubMed ID: 12607020
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe anaphylactic reaction after repeated intermittent exposure to lepirudin.
    Veach SA; Franks AM; Allan MC
    Pharmacotherapy; 2007 May; 27(5):760-5. PubMed ID: 17461712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
    Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of hirudins in percutaneous coronary intervention and the risk of Kounis syndrome.
    Kounis NG; Kounis SA; Kounis GN; Hahalis G
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):584-5. PubMed ID: 19085914
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction.
    Bircher AJ; Czendlik CH; Messmer SL; Müller P; Howald H
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):994-6. PubMed ID: 8939165
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biventricular thrombi dissolution and antibody development with lepirudin therapy].
    Skowasch D; Pötzsch B; Kuntz-Hehner S; Gampert T; Rox J; Omran H; Bauriedel G; Lüderitz B
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1531-4. PubMed ID: 12854062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 13. Kounis syndrome during general anaesthesia and administration of adrenaline.
    Takenaka I; Okada E; Aoyama K; Iwagaki T; Kadoya T
    Int J Cardiol; 2012 Jan; 154(2):e34-5. PubMed ID: 21640413
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biventricular thrombus resolution and antibody formation during lepirudin therapy. Comment on the article from DMW 28-29/2003].
    Nowak G
    Dtsch Med Wochenschr; 2003 Nov; 128(45):2389-90; author reply 2390. PubMed ID: 14606040
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged bleeding after cardiopulmonary bypass with recombinant hirudin in heart transplantation.
    Kwapisz MM; Schindler E; Müller M; Akintürk H
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):256-7. PubMed ID: 10485435
    [No Abstract]   [Full Text] [Related]  

  • 16. Type I and Type IV allergy to unfractionated heparin and low-molecular-weight heparin with no reaction to recombinant hirudin.
    Hallai N; Hughes TM; Stone N
    Contact Dermatitis; 2004 Sep; 51(3):153-4. PubMed ID: 15479209
    [No Abstract]   [Full Text] [Related]  

  • 17. The anticoagulant and antithrombotic properties of hirudins.
    Märki WE; Wallis RB
    Thromb Haemost; 1990 Nov; 64(3):344-8. PubMed ID: 2096484
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in antithrombotic therapy: novel agents.
    Turpie AG; Weitz JI; Hirsh J
    Thromb Haemost; 1995 Jul; 74(1):565-71. PubMed ID: 8578525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboons.
    Meiring SM; Lötter MG; Badenhorst PN; Bucha E; Nowak G; Kotzé HF
    J Pharm Sci; 1999 May; 88(5):523-9. PubMed ID: 10229643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desirudin (Iprivask) for DVT prevention.
    Med Lett Drugs Ther; 2010 Nov; 52(1350):85-6. PubMed ID: 21045759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.